Azithromycin 250 mg identifies an oral tablet containing 250 mg of azithromycin. It does not identify the total prescription quantity, whether a branded pack was requested, or a medically suitable schedule. Shoppers comparing 250 mg listings should therefore treat strength as only one part of the written pharmacy order.
The same tablet strength can appear in standard brand or generic packages and in the familiar Z-Pak six-tablet presentation. FDA labeling describes these as oral tablets. A pharmacy might display prices per tablet or per specified number of tablets; those amounts should not be compared without verifying the complete fill.
This page focuses on the 250 mg unit strength and its dispensing variants. For a broader classification of tablet forms, visit the azithromycin tablet hub. For a different tablet strength rather than a different pack, use the 500 mg tablet guide.
Tablet strength is the drug quantity per dosage unit. Prescription directions also describe when and how many tablets to take, as determined by the clinician. A 250 mg tablet can participate in different labeled regimens, depending on the clinical setting.
Do not use the number on a pharmacy listing to choose a treatment schedule or change prescribed instructions. Antibiotic stewardship and suitability are separate from product strength.
| Listing example | What is known | What still needs verification |
|---|---|---|
| Azithromycin 250 mg tablet | Unit strength and oral form | Count, directions and generic/brand status |
| Six × 250 mg Z-Pak | Brand pack and tablet count | Whether exactly that pack is prescribed |
| Generic 250 mg bottle | Generic product with the stated strength | Manufacturer/NDC, actual dispensed quantity |
| Liquid azithromycin | Not a 250 mg tablet product | Liquid concentration and prescribed volume |
The well-known branded Z-Pak presentation contains six 250 mg tablets. Yet not every 250 mg azithromycin tablet fill is a Z-Pak; some are ordinary tablets dispensed into a vial or another packaging format.
The brand package matters if specifically named in the prescription, listed by the pharmacy or priced as a separate SKU. Otherwise the important identifiers are the legally dispensable product, strength, quantity and directions.
A generic listing may show a manufacturer, pill appearance, NDC and pack count, none of which alone implies a different active ingredient when the drug is an appropriately approved equivalent. Packaging appearance should be distinguished from regulatory equivalence.
Read the generic product guide for the FDA evaluation process. If the supplied tablets look unfamiliar, have the pharmacist identify them against the prescription.
Oral liquids express azithromycin as mg per 5 mL after reconstitution, not mg per tablet. A tablet strength and a bottle concentration are not equivalent product identifiers. A formulation change may also alter measuring and administration requirements.
For oral-liquid concentrations, the suspension hub covers the relevant labeling; this page does not calculate doses or recommend a route change.
Two pharmacies may display different per-tablet amounts because one listing covers a branded package, another a generic stock bottle, and another a different count. An apples-to-apples comparison requires the same strength and prescribed quantity.
Use the full pharmacy-cost guide for the broader list of price variables. A coupon on a generic six-count fill need not apply to a branded Z-Pak.
An NDC helps identify a particular labeler, product and package, but it does not by itself guarantee FDA approval or current inventory. Confirm the exact approved product through appropriate FDA resources when needed and verify availability directly with the pharmacy.
At pickup compare the prescription with the label for azithromycin, 250 mg, tablet form, quantity and directions. Unexpected changes deserve a pharmacist explanation.
Ask: “Can you verify the price of the prescribed azithromycin 250 mg tablets for this exact quantity, and tell me whether the quoted item is branded or generic?” That wording avoids asking a pharmacy to guess the intended regimen.
If the pharmacy cannot supply the exact item, ask how it would obtain an approved alternative and whether prescriber confirmation is required.
A six-count 250 mg pack and a three-count 500 mg pack contain equal total milligrams, but differ in strength and labeled administration. The pharmacist should resolve any apparent mismatch.
The Z-Pak and Tri-Pak comparison addresses that packaging distinction without turning it into self-directed dosage guidance.
It is the amount of active azithromycin in one tablet, not a complete regimen.
No. The brand pack is one presentation; generic or other tablet packs also exist.
No. Follow the individual prescription directions and clinician guidance.
No. Any change in formulation must be checked by a pharmacist or prescriber.
No. Approved products can differ in appearance and inactive components.
A lower tablet strength by itself does not establish safety or appropriateness; regimen and patient factors matter.
No. NDC listings identify products, not live inventory.